Clinical trial
Evaluation of Hydroxyurea Plus L-arginine or Sildenafil to Treat Sickle Cell…
NCT00056433 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00056433 |
|---|---|
| Title | Evaluation of Hydroxyurea Plus L-arginine or Sildenafil to Treat Sickle Cell Anemia |
| Official title | Evaluation of Potential Synergy of Combining Hydroxyurea With Nitric Oxide Donors on Fetal Hemoglobin Synthesis in Patients With Sickle Cell Anemia |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Sickle Cell Anemia |
| Intervention type | Drug |
| Interventions | Hydroxyurea, L-Arginine, Sildenafil |
| Enrollment | 39 |
| Start date | Mar 10, 2003 |
| Primary completion | Dec 27, 2006 |
| Completion | Dec 27, 2006 |
| First posted | Mar 13, 2003 |
| Last update posted | Nov 22, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: